Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zolpidem-containing medicines regulatory update

FDA will require manufacturers of zolpidem-containing insomnia drugs to lower the recommended doses for women and suggest that prescribers consider lower doses for men. The

Read the full 251 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE